Lexicon Pharmaceuticals
LXRX
#6866
Rank
NZ$1.02 B
Marketcap
NZ$2.46
Share price
-3.29%
Change (1 day)
98.97%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): NZ-$0.34

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.32. In 2024 the company made an earnings per share (EPS) of NZ-$1.07 an increase over its 2023 EPS that were of NZ-$1.34.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.34-68.62%
2024NZ-$1.07-20%
2023NZ-$1.3431.15%
2022NZ-$1.02-0%
2021NZ-$1.0210.91%
2020NZ-$0.92-145.08%
2019NZ$2.04-206.09%
2018NZ-$1.92-5.74%
2017NZ-$2.04-10.95%
2016NZ-$2.292640%
2015NZ-$0.08355-96.34%
2014NZ-$2.28-2.53%
2013NZ-$2.34-9.09%
2012NZ-$2.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$29.69-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.47-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$72.05-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$9.93 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$3.99-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.84 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.25 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$4.55-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$128.18 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA